Company Overview
More
Pilot Pharmaceutical and Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in pharmaceutical and biotechnology business. The company operates through five major divisions. The genetic testing Services Division provides genetic testing services in China and Hong Kong. Bio-industry products division distributes bio-industry products in China. Beauty equipment and products Trading Division is engaged in the trade of beauty equipment and products in Hong Kong. The securities investment division engages in securities investment in and outside Hong Kong. The R & D division is engaged in the R & D and commercialization of oral insulin products.
CEO： Nian Jiang
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
00399 INNOVATIVE PHAR
0.186+0.002+1.09%
Market Close 05/23 16:08 CCT
High
0.186
Open
0.181
Turnover
38.20K
Low
0.180
Pre Close
0.184
Volume
211.74K
Price Forecast
No Data
News
Comment
INNOVATIVE PHAR: Interim Report 2021-2022
INNOVATIVE PHAR: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021
INNOVATIVE PHAR: Profit Alert
INNOVATIVE PHAR: NOTIFICATION OF BOARD MEETING
INNOVATIVE PHAR: Annual Report 2021
INNOVATIVE PHAR: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2021
INNOVATIVE PHAR: NOTIFICATION OF BOARD MEETING
INNOVATIVE PHAR: Interim Report 2020-2021
INNOVATIVE PHAR: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2020
INNOVATIVE PHAR: NOTIFICATION OF BOARD MEETING